Tuesday, 24 June 2025 »  Login
in
»
I am at

Dr Reddy's Labs' Covid-19 Drug Gets DCGI Nod

A new drug for the treatment of Covid-19, developed by pharma giant Dr Reddy's Labs and the INMAS, has been okayed for emergency use by the DCGI.
Hyderabad | 9th May 2021
A potential cancer drug, 2-deoxy-D-glucose (2-DG), that was reprocessed as medication for Covid-19 patients by pharma giant Dr Reddy's Laboratories in collaboration with the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab run by the Defence Research and Development Organisation (DRDO), has been okayed for emergency use by the Drugs Controller General of India (DCGI).

2-DG, a powder that comes in individual sachets and has to be administered orally in a water-based solution, can help prevent the growth of coronavirus in an infected person besides reducing patients' dependence on artificial oxygen. This was seen during the trial phase last year. The tests also showed that persons who had tested positive for Covid-19, tested negative faster after using the wonder drug.

Talking about the medicine, officials of the two labs said that it was suitable for use on critical Covid-19 patients. Those with moderate symptoms will also benefit from its use.

The drug's ability to reduce patients' dependence on supplemental oxygen will be a great boon especially as the ongoing second wave of the pandemic has left many infected persons entirely reliant on medical oxygen. Where many states of the country have been severely affected by both the pandemic and a huge shortage of oxygen this new medication could help scores of patients recover despite the deficit of medical oxygen.

Since it has already been patented and has also been okayed for use by the DCGI, reports say that 2-DG is expected to hit the market in about a week.

Telangana's case figures meanwhile highlight exactly why such a drug will be a godsend - the state recorded 4,976 new positives after 55,358 samples were tested as well as 35 fresh fatalities in the last 24 hours.

Further, three patients passed away at King Koti Hospital due to lack of access to medical oxygen. The oxygen tanker which was supposed to reach the facility from Jadcherla got delayed as the driver of the tanker forgot the route.

The incident prompted the three bereaved families to stage a dharna outside the hospital. They demanded that the hospital authorities take action against those responsible for the lapse.
filed in:  Healthcare, Pharma Industry, Dr. Reddy's Labs, DRDO, Coronavirus, Epidemics, Health
COMMENTS
Be the first to comment on Dr Reddy's Labs' Covid-19 Drug Gets DCGI Nod! Just use the simple form below.
LEAVE A COMMENT
fullhyd.com has 700,000+ monthly visits. Tell Hyderabad what you feel about Dr Reddy's Labs' Covid-19 Drug Gets DCGI Nod!
[no link to your name will appear, overriding global settings]
To preserve integrity, fullhyd.com allows ratings/comments only with a valid email. Your comments will be accepted once you give your email, and will be deleted if the email is not authenticated within 24 hours.
My name:

Dissatisfied with the results? Report a problem or error, or add a listing.
ADVERTISEMENT
SHOUTBOX!
{{todo.name}}
{{todo.date}}
[
]
{{ todo.summary }}... expand »
{{ todo.text }} « collapse
First  |  Prev  |   1   2  3  {{current_page-1}}  {{current_page}}  {{current_page+1}}  {{last_page-2}}  {{last_page-1}}  {{last_page}}   |  Next  |  Last
{{todos[0].name}}

{{todos[0].text}}

ADVERTISEMENT
This page was tagged for
hyderabad May 2021 News
Healthcare news
Pharma Industry updates
Follow fullhyd.com on
Copyright © 2023 LRR Technologies (Hyderabad) Pvt Ltd. All rights reserved. fullhyd and fullhyderabad are registered trademarks of LRR Technologies (Hyderabad) Pvt Ltd. The textual, graphic, audio and audiovisual material in this site is protected by copyright law. You may not copy, distribute or use this material except as necessary for your personal, non-commercial use. Any trademarks are the properties of their respective owners.